These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
650 related articles for article (PubMed ID: 28605011)
21. Clinical evolution and epilepsy outcome in three patients with CDKL5-related developmental encephalopathy. Bernardo P; Ferretti A; Terrone G; Santoro C; Bravaccio C; Striano S; Coppola A; Striano P Epileptic Disord; 2019 Jun; 21(3):271-277. PubMed ID: 31225800 [TBL] [Abstract][Full Text] [Related]
22. Six-month efficacy of the Ketogenic diet is predicted after 3 months and is unrelated to clinical variables. Wu YJ; Zhang LM; Chai YM; Wang J; Yu LF; Li WH; Zhou YF; Zhou SZ Epilepsy Behav; 2016 Feb; 55():165-9. PubMed ID: 26785223 [TBL] [Abstract][Full Text] [Related]
23. Ketogenic diet therapy in infants less than two years of age for medically refractory epilepsy. Ismayilova N; Leung MA; Kumar R; Smith M; Williams RE Seizure; 2018 Apr; 57():5-7. PubMed ID: 29524777 [TBL] [Abstract][Full Text] [Related]
24. Two Novel Variants Affecting CDKL5 Transcript Associated with Epileptic Encephalopathy. Neupauerová J; Štěrbová K; Vlčková M; Sebroňová V; Maříková T; Krůtová M; David S; Kršek P; Žaliová M; Seeman P; Laššuthová P Genet Test Mol Biomarkers; 2017 Oct; 21(10):613-618. PubMed ID: 28872899 [TBL] [Abstract][Full Text] [Related]
25. CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients. Archer HL; Evans J; Edwards S; Colley J; Newbury-Ecob R; O'Callaghan F; Huyton M; O'Regan M; Tolmie J; Sampson J; Clarke A; Osborne J J Med Genet; 2006 Sep; 43(9):729-34. PubMed ID: 16611748 [TBL] [Abstract][Full Text] [Related]
26. Ketogenic diet use in children with intractable epilepsy secondary to malformations of cortical development: A two- centre experience. Pasca L; Caraballo RH; De Giorgis V; Reyes JG; Macasaet JA; Masnada S; Armeno M; Musicco M; Tagliabue A; Veggiotti P Seizure; 2018 Apr; 57():34-37. PubMed ID: 29554640 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus. Arya R; Peariso K; Gaínza-Lein M; Harvey J; Bergin A; Brenton JN; Burrows BT; Glauser T; Goodkin HP; Lai YC; Mikati MA; Fernández IS; Tchapyjnikov D; Wilfong AA; Williams K; Loddenkemper T; Epilepsy Res; 2018 Aug; 144():1-6. PubMed ID: 29727818 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of ketogenic diet in CDKL5-related epilepsy: a single arm meta-analysis. Zhang J; Ma J; Chang X; Wu P; Li S; Wu Y Orphanet J Rare Dis; 2022 Oct; 17(1):385. PubMed ID: 36274176 [TBL] [Abstract][Full Text] [Related]
29. The efficacy comparison of classic ketogenic diet and modified Atkins diet in children with refractory epilepsy: a clinical trial. Poorshiri B; Barzegar M; Tahmasebi S; Shiva S; Raeisi S; Ebadi Z Acta Neurol Belg; 2021 Apr; 121(2):483-487. PubMed ID: 31677042 [TBL] [Abstract][Full Text] [Related]
30. Xp22.3 genomic deletions involving the CDKL5 gene in girls with early onset epileptic encephalopathy. Mei D; Marini C; Novara F; Bernardina BD; Granata T; Fontana E; Parrini E; Ferrari AR; Murgia A; Zuffardi O; Guerrini R Epilepsia; 2010 Apr; 51(4):647-54. PubMed ID: 19780792 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of Ketogenic Diet, Modified Atkins Diet, and Low Glycemic Index Therapy Diet Among Children With Drug-Resistant Epilepsy: A Randomized Clinical Trial. Sondhi V; Agarwala A; Pandey RM; Chakrabarty B; Jauhari P; Lodha R; Toteja GS; Sharma S; Paul VK; Kossoff E; Gulati S JAMA Pediatr; 2020 Oct; 174(10):944-951. PubMed ID: 32761191 [TBL] [Abstract][Full Text] [Related]
32. Historic, clinical, and prognostic features of epileptic encephalopathies caused by CDKL5 mutations. Moseley BD; Dhamija R; Wirrell EC; Nickels KC Pediatr Neurol; 2012 Feb; 46(2):101-5. PubMed ID: 22264704 [TBL] [Abstract][Full Text] [Related]
33. Clinical features of early myoclonic encephalopathy caused by a CDKL5 mutation. Takeda K; Miyamoto Y; Yamamoto H; Ishii A; Hirose S; Yamamoto H Brain Dev; 2020 Jan; 42(1):73-76. PubMed ID: 31492455 [TBL] [Abstract][Full Text] [Related]
34. Ketogenic diet effects on 52 children with pharmacoresistant epileptic encephalopathy: A clinical prospective study. Wu Q; Wang H; Fan YY; Zhang JM; Liu XY; Fang XY; Yang FH; Cao QJ; Qi Y Brain Behav; 2018 May; 8(5):e00973. PubMed ID: 29761022 [TBL] [Abstract][Full Text] [Related]
36. Ketogenic Diet for Refractory Childhood Epilepsy: Beyond Seizures Control, the Experience of a Portuguese Pediatric Centre. Romão Luz I; Pereira C; Garcia P; Ferreira F; Faria A; Macedo C; Diogo L; Robalo C Acta Med Port; 2019 Dec; 32(12):760-766. PubMed ID: 31851885 [TBL] [Abstract][Full Text] [Related]
37. Concomitant lamotrigine use is associated with decreased efficacy of the ketogenic diet in childhood refractory epilepsy. van der Louw EJ; Desadien R; Vehmeijer FO; van der Sijs H; Catsman-Berrevoets CE; Neuteboom RF Seizure; 2015 Nov; 32():75-7. PubMed ID: 26552568 [TBL] [Abstract][Full Text] [Related]
38. Ketogenic Diet in patients with refractory epilepsy. Rebollo G MJ; Díaz Sm X; Soto R M; Pacheco A J; Witting E S; Daroch R I; Moraga M F Rev Chil Pediatr; 2020 Oct; 91(5):697-704. PubMed ID: 33399634 [TBL] [Abstract][Full Text] [Related]
39. ATN1-related infantile developmental and epileptic encephalopathy responding to Ketogenic diet. Xie Y; Su T; Liu Y; Xu S Seizure; 2024 Apr; 117():1-5. PubMed ID: 38262122 [TBL] [Abstract][Full Text] [Related]
40. The Impact of 3:1 Ketogenic Diet on Cardiac Repolarization Changes in Children with Refractory Seizures: A Prospective Follow-Up Study. Özdemir R; Güzel O; Küçük M; Karadeniz C; Yılmaz Ü; Calik T; Meşe T Neuropediatrics; 2016 Jun; 47(3):157-61. PubMed ID: 27043293 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]